Clinical Trial: Teplizumab in Pediatric Stage 2 Type 1 Diabetes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Type 1 Diabetes
Study Type: INTERVENTIONAL
Official Title: Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen of Teplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least Two Autoant
Brief Summary:
The purpose of this study is to assess the safety and PK of teplizumab in participants with Stage 2 type 1 diabetes who are <8 years of age.
Read more